Breaking News

GSK Extends 340B Pricing Conditions to all Covered Entities and all Products

GlaxoSmithKline wordmark and GSK logo on a building
Drugmaker GSK owes refunds to certain 340B providers for its asthma product Nucala, a notice posted to a government site said.

UPDATE Friday, March 31, 2023, 6:45 p.m. EDT—Story updated with comment from the National Association of Community Health Centers.


Drug manufacturer GlaxoSmithKline this afternoon announced a major expansion of its conditions on 340B pricing in the contract

Read More »

News Alert

Pfizer Is the Second Drug Maker This Week to Tighten Limits on 340B Sales to Hospitals

Pfizer company name on a building
Drug manufacturer Pfizer stiffened its conditions on 340B sales to hospitals of the immunosuppressant Xeljanz.

Drug manufacturer Pfizer today stiffened its conditions on 340B sales to hospitals of the immunosuppressant Xeljanz, one of its top-selling products.

Starting May 1, Pfizer will let hospitals without an in-house pharmacy designate just one contract pharmacy for Xeljanz. Pfizer

Read More »

ASAP 340B Hires Executive Director and Publishes FAQ in Response to Questions and Criticism

ASAP 340B partnership wordmark
ASAP 340B this week announced it hired an executive director and published an FAQ that responds to questions and criticism.

ASAP 340B, the nonprofit group that the drug industry and health centers formed to help advance their joint plan to remake the 340B program, has hired an executive director and published an FAQ that responds to questions and criticism. “There

Read More »

AIDS Healthcare Foundation Protests Against PhRMA/NACHC Alliance During 340B Coalition Conference

Protesters carry placards in support of the 340B drug pricing program and AHF
AIDS Healthcare Foundation held a protest march Tuesday at the 340B Coalition winter conference in California against the PhRMA/NACHC alliance to change the 340B program.

AIDS Healthcare Foundation held two demonstrations Tuesday—one outdoors and loud, the other indoors and silent—at the 340B Coalition winter conference in California to protest against the new drug industry/community health center alliance to change the 340B program.

“Let’s be clear.

Read More »

The Top 5 Marketing Tips for Building Your Patient Base

digital hands of doctor holding heart symbol

SPONSORED CONTENT

Saving people’s lives.
Eliminating the stigma surrounding a host of physical and mental health conditions.
Advocating for the health equity of underserved populations.
Executing targeted marketing campaigns.

One of these initiatives indeed feels less service-oriented than the others. But once you kick all

Read More »

As April 1 Deadline Looms, NY Health Centers Urge Courts to Stop Medicaid Pharmacy Benefit Transfer

340B program advocates hold a die-in outside New York Gov. Kathy Hochul's office
New York state Sen. Robert Jackson (center, holding green sign) participated in a "die-in" outside of Gov. Kathy Hochul's office on Tuesday to protest the scheduled transfer of Medicaid managed care drug benefits to Medicaid fee for service on Saturday.

If New York State transfers Medicaid managed care drug benefits to Medicaid fee for service on Saturday as scheduled, “it will all but eliminate the savings that safety-net providers have realized through the 340B program and the revenues on which

Read More »

HRSA Allows Immediate 340B Enrollment in Mississippi Due to Tornadoes

Tornado damage
Health care providers in Mississippi can enroll in 340B immediately under program flexibilities granted in response to March 24 tornadoes that killed 21.

Health care providers in Mississippi eligible to participate in the 340B program may do so immediately, rather than having to wait for the next normal quarterly registration period July 1-15, federal health officials said yesterday.

Strong tornadoes struck the state

Read More »

News Alert

HHS Secretary: 340B “Doesn’t Have the Transparency We Need”

United States Secretary of Health and Human Services Xavier Becerra speaks at Health Subcommittee hearing
The 340B program “doesn’t have the transparency we need,” HHS Secretary Becerra said during a House Energy & Commerce subcommittee hearing today.

U.S. Health and Human Services Secretary Xavier Becerra said today that the 340B program “doesn’t have the transparency we need” and “we are going to do what we can to make it more transparent.”

Becerra was asked about the drug

Read More »

News Alert

AbbVie Puts Squeeze on 340B Pricing for Hospitals Akin to J&J and Amgen’s Recent Moves

AbbVie facility gate
AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals, along the lines of Amgen and Johnson & Johnson's recent moves.

Drug manufacturer AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals.

AbbVie has not yet responded to a request for comment about the changes. Non-hospital covered entities continue to be exempt from AbbVie’s pricing restrictions.

Drug manufacturers

Read More »

News Alert

U.S. House Panel Debates 340B in Context of Health Care Transparency and Consolidation

Congresswoman Doris Matsui
“There’s been a lot of criticism of the 340B program lately and I’m concerned about the conversation on 340B happening today,” Rep. Doris Matsui (D-Calif.) said during a House Energy & Commerce health subcommittee hearing today.

The 340B program was discussed at length today during a U.S. House subcommittee hearing on price transparency and consolidation in health care, with three Republicans questioning whether hospitals are abusing the program and two Democrats and a Republican cautioning against

Read More »